188 related articles for article (PubMed ID: 12481899)
1. Antisense oligonucleotides complementary to Bax transcripts reduce the susceptibility of B-cell chronic lymphocytic leukaemia cells to apoptosis in a bcl-2 independent manner.
Pepper C; Thomas A; Hoy T; Bentley P
Leuk Lymphoma; 2002 Oct; 43(10):2003-9. PubMed ID: 12481899
[TBL] [Abstract][Full Text] [Related]
2. Bcl-2 antisense oligonucleotides enhance the cytotoxicity of chlorambucil in B-cell chronic lymphocytic leukaemia cells.
Pepper C; Hooper K; Thomas A; Hoy T; Bentley P
Leuk Lymphoma; 2001 Jul; 42(3):491-8. PubMed ID: 11699414
[TBL] [Abstract][Full Text] [Related]
3. Antisense-mediated suppression of Bcl-2 highlights its pivotal role in failed apoptosis in B-cell chronic lymphocytic leukaemia.
Pepper C; Thomas A; Hoy T; Cotter F; Bentley P
Br J Haematol; 1999 Dec; 107(3):611-5. PubMed ID: 10583267
[TBL] [Abstract][Full Text] [Related]
4. Chlorambucil resistance in B-cell chronic lymphocytic leukaemia is mediated through failed Bax induction and selection of high Bcl-2-expressing subclones.
Pepper C; Thomas A; Hoy T; Bentley P
Br J Haematol; 1999 Mar; 104(3):581-8. PubMed ID: 10086798
[TBL] [Abstract][Full Text] [Related]
5. Antisense Bcl-xl down-regulation switches the response to topoisomerase I inhibition from senescence to apoptosis in colorectal cancer cells, enhancing global cytotoxicity.
Hayward RL; Macpherson JS; Cummings J; Monia BP; Smyth JF; Jodrell DI
Clin Cancer Res; 2003 Jul; 9(7):2856-65. PubMed ID: 12855666
[TBL] [Abstract][Full Text] [Related]
6. Enhanced oxaliplatin-induced apoptosis following antisense Bcl-xl down-regulation is p53 and Bax dependent: Genetic evidence for specificity of the antisense effect.
Hayward RL; Macpherson JS; Cummings J; Monia BP; Smyth JF; Jodrell DI
Mol Cancer Ther; 2004 Feb; 3(2):169-78. PubMed ID: 14985457
[TBL] [Abstract][Full Text] [Related]
7. P53, MDM-2, BAX and BCL-2 and drug resistance in chronic lymphocytic leukemia.
Johnston JB; Daeninck P; Verburg L; Lee K; Williams G; Israels LG; Mowat MR; Begleiter A
Leuk Lymphoma; 1997 Aug; 26(5-6):435-49. PubMed ID: 9389352
[TBL] [Abstract][Full Text] [Related]
8. Elevated Bcl-2/Bax are a consistent feature of apoptosis resistance in B-cell chronic lymphocytic leukaemia and are correlated with in vivo chemoresistance.
Pepper C; Hoy T; Bentley P
Leuk Lymphoma; 1998 Jan; 28(3-4):355-61. PubMed ID: 9517506
[TBL] [Abstract][Full Text] [Related]
9. Antisense oligodeoxynucleotides to bax mRNA promote survival of rat sympathetic neurons in culture.
Gillardon F; Zimmermann M; Uhlmann E; Krajewski S; Reed JC; Klimaschewski L
J Neurosci Res; 1996 Mar; 43(6):726-34. PubMed ID: 8984202
[TBL] [Abstract][Full Text] [Related]
10. Drug-induced apoptosis in B-cell chronic lymphocytic leukemia: relationship between p53 gene mutation and bcl-2/bax proteins in drug resistance.
Thomas A; El Rouby S; Reed JC; Krajewski S; Silber R; Potmesil M; Newcomb EW
Oncogene; 1996 Mar; 12(5):1055-62. PubMed ID: 8649796
[TBL] [Abstract][Full Text] [Related]
11. Retinoid-induced apoptosis in B-cell chronic lymphocytic leukaemia cells is mediated through caspase-3 activation and is independent of p53, the retinoic acid receptor, and differentiation.
Pepper C; Ali K; Thomas A; Hoy T; Fegan C; Chowdary P; Kell J; Bentley P
Eur J Haematol; 2002 Oct; 69(4):227-35. PubMed ID: 12431242
[TBL] [Abstract][Full Text] [Related]
12. Increased apoptosis in B-chronic lymphocytic leukemia cells as a result of cyclin D3 down regulation.
Wang P; Pavletic ZS; Joshi SS
Leuk Lymphoma; 2002 Sep; 43(9):1827-35. PubMed ID: 12685840
[TBL] [Abstract][Full Text] [Related]
13. Flavopiridol circumvents Bcl-2 family mediated inhibition of apoptosis and drug resistance in B-cell chronic lymphocytic leukaemia.
Pepper C; Thomas A; Hoy T; Fegan C; Bentley P
Br J Haematol; 2001 Jul; 114(1):70-7. PubMed ID: 11472347
[TBL] [Abstract][Full Text] [Related]
14. Bcl-2 and bax expression and chlorambucil-induced apoptosis in the T-cells and leukaemic B-cells of untreated B-cell chronic lymphocytic leukaemia patients.
Thomas A; Pepper C; Hoy T; Bentley P
Leuk Res; 2000 Oct; 24(10):813-21. PubMed ID: 10996199
[TBL] [Abstract][Full Text] [Related]
15. P53 mediates ceramide-induced apoptosis in SKN-SH cells.
Kim SS; Chae HS; Bach JH; Lee MW; Kim KY; Lee WB; Jung YM; Bonventre JV; Suh YH
Oncogene; 2002 Mar; 21(13):2020-8. PubMed ID: 11960374
[TBL] [Abstract][Full Text] [Related]
16. Bax antisense oligonucleotides reduce axotomy-induced retinal ganglion cell death in vivo by reduction of Bax protein expression.
Isenmann S; Engel S; Gillardon F; Bähr M
Cell Death Differ; 1999 Jul; 6(7):673-82. PubMed ID: 10453078
[TBL] [Abstract][Full Text] [Related]
17. CD6 ligation modulates the Bcl-2/Bax ratio and protects chronic lymphocytic leukemia B cells from apoptosis induced by anti-IgM.
Osorio LM; De Santiago A; Aguilar-Santelises M; Mellstedt H; Jondal M
Blood; 1997 Apr; 89(8):2833-41. PubMed ID: 9108402
[TBL] [Abstract][Full Text] [Related]
18. Relationship between nitrogen mustard drug resistance in B-cell chronic lymphocytic leukemia (B-CLL) and protein expression of Bcl-2, Bax, Bcl-X and p53.
Christodoulopoulos G; Fotouhi N; Krajewski S; Reed JC; Alaoui-Jamali M; Panasci L
Cancer Lett; 1997 Dec; 121(1):59-67. PubMed ID: 9459175
[TBL] [Abstract][Full Text] [Related]
19. Abnormal intracellular level of Bax in CD3+ cells from untreated B-cell chronic lymphocytic leukemia patients.
Scamardella F; Maconi M; Albertazzi L; Gamberi B; Gugliotta L; Brini M
Lab Hematol; 2006; 12(4):187-92. PubMed ID: 17118768
[TBL] [Abstract][Full Text] [Related]
20. Bcl-2, Bax and p53 expression in B-CLL in relation to in vitro survival and clinical progression.
Aguilar-Santelises M; Rottenberg ME; Lewin N; Mellstedt H; Jondal M
Int J Cancer; 1996 Apr; 69(2):114-9. PubMed ID: 8608978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
